|
P-200 A phase II study of dose reductive XELOX plus bevacizumab in elderly or vulnerable patients with metastatic colorectal cancer: MCSGO-1202 |
|
|
|
Title: |
P-200 A phase II study of dose reductive XELOX plus bevacizumab in elderly or vulnerable patients with metastatic colorectal cancer: MCSGO-1202 |
Author: |
Nakata, K. Sakai, D. Hasegawa, J. Kato, T. Murata, K. Ikenaga, M. Kudo, T. Uemura, M. Satoh, T. Mizushima, T. Doki, Y. Eguchi, H. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 32 () nr. S3 pages S168 |
Year: |
2021 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|